2015
Pre‐therapy inflammation and coagulation activation and long‐term CD4 count responses to the initiation of antiretroviral therapy
Achhra A, Phillips A, Emery S, MacArthur R, Furrer H, De Wit S, Losso M, Law, groups I. Pre‐therapy inflammation and coagulation activation and long‐term CD4 count responses to the initiation of antiretroviral therapy. HIV Medicine 2015, 16: 449-454. PMID: 25959989, PMCID: PMC5676307, DOI: 10.1111/hiv.12258.Peer-Reviewed Original ResearchConceptsCD4 count responseBaseline CD4 countC-reactive proteinCD4 countART initiationClinical outcomesCoagulation activationBiomarker levelsInterleukin-6Therapy trialsMedian baseline CD4 countAntiretroviral Therapy (SMART) trialFirst-line ARTInflammatory marker levelsHIV-positive individualsLong-term CD4CD4 count measurementCD4 responseART-naïveCent of individualsStudy armsD-dimerCount responseMean ageMarker levels
2012
Race and CD4+ T-cell count in HIV prognosis and treatment
Achhra A, Amin J. Race and CD4+ T-cell count in HIV prognosis and treatment. Future Virology 2012, 7: 193-203. DOI: 10.2217/fvl.11.143.Peer-Reviewed Original ResearchT-cell countsFuture long-term trialsHIV-negative individualsHIV clinical studiesHIV/AIDSLong-term trialsTherapy initiationProspective cohortClinical outcomesHIV prognosisClinical significanceClinical studiesCD4Current evidenceRacial differencesCountRecent studiesDiverse populationsHIVPrognosisTherapyCohortRaceAIDSDifferences